EBEligo Bioscience Team
Eligo Bioscience
Last updated: February 23, 2026
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals. Healthcare Biotech
Khosla Ventures, $23M Series A in 2020
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals. Healthcare Biotech
Khosla Ventures, $23M Series A in 2020
- Series A • Khosla Ventures, $23M Series A in 2020
Founder Intelligence Brief: Eligo Bioscience Team
This profile is built to help readers move from a founder name to decision-ready context. Eligo Bioscience Team is mapped to Eligo Bioscience in the Healthcare category, with current stage context as Series A. The primary operating market is Paris, France, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $23.00M, with the latest mapped round as Series A (Khosla Ventures, $23M Series A in 2020). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Healthcare startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Healthcare industry routes and Series A stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: France directory.
- Stage signal: Series A funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Healthcare.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About Eligo Bioscience Team
Common questions people ask about this profile.
Who is Eligo Bioscience Team?
Eligo Bioscience Team is the founder profile listed on 100Xfounder for Eligo Bioscience, tracked for market signals, company intelligence, and operator-level context.
What does Eligo Bioscience do?
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals. Healthcare Biotech
Where is Eligo Bioscience based?
Eligo Bioscience is listed as operating from Paris, France.
What is the current funding stage of Eligo Bioscience?
Eligo Bioscience is currently categorized at Series A on 100Xfounder. Funding signal: Khosla Ventures, $23M Series A in 2020
What is the latest funding round for Eligo Bioscience?
The latest tracked round for Eligo Bioscience is Series A Khosla Ventures, $23M Series A in 2020. Total tracked rounds: 1.
Is Eligo Bioscience hiring right now?
Current hiring signal for Eligo Bioscience: Open Roles.
Is Eligo Bioscience Team's profile verified?
Yes. Eligo Bioscience Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with Eligo Bioscience Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.eligo-bioscience.com.
What technologies are associated with Eligo Bioscience?
Eligo Bioscience is associated with Python, GCP, BigQuery, and React based on current profile intelligence.